Regenerative Medical Technology Group Inc.
RMTG
$0.047
$0.014845.96%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 53.18% | 24.33% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 53.18% | 24.33% | |||
| Cost of Revenue | 121.82% | -10.21% | |||
| Gross Profit | 31.20% | 41.79% | |||
| SG&A Expenses | -1.61% | 0.08% | |||
| Depreciation & Amortization | -131.31% | 6.99% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.09% | -2.11% | |||
| Operating Income | 1,558.01% | 112.11% | |||
| Income Before Tax | 28.06% | 57.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 28.06% | 57.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 28.06% | 57.28% | |||
| EBIT | 1,558.01% | 112.11% | |||
| EBITDA | 291.51% | 203.80% | |||
| EPS Basic | 28.11% | 57.40% | |||
| Normalized Basic EPS | 28.05% | 57.46% | |||
| EPS Diluted | 28.11% | 57.40% | |||
| Normalized Diluted EPS | 28.05% | 57.46% | |||
| Average Basic Shares Outstanding | 0.00% | 0.36% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||